Angiogenesis inhibitor was the largest segment of the global non-small cell lung cancer
market in 2014.
com/research/bzq595/global_nonsmall) has announced the addition of the "Global Non-small Cell Lung Cancer
Drugs Market 2012-2016" report to their offering.
21, 2015 /PRNewswire/ -- The Non-Small Cell Lung Cancer
Partnering 2010-2015 report provides understanding and access to the non-small cell lung cancer
partnering deals and agreements entered into by the worlds leading healthcare companies.
com/research/gv8qwl/global_nonsmall) has announced the addition of the "Global Non-small Cell Lung Cancer
Drug Pipeline Capsule - 2012 Update" report to their offering.
7, 2015 /PRNewswire-iReach/ --ACCESS REPORT @ Squamous Non-Small Cell Lung Cancer
- Pipeline Review, H2 2015
com/research/l8p5hj/global_nonsmall) has announced the addition of the "Global Non-Small Cell Lung Cancer
Epidemiology and Patient Flow Analysis - 2012" report to their offering.
24, 2014 /PRNewswire/ -- About Non-small Cell Lung Cancer Non-small cell lung cancer
occurs when normal cells grow and multiply without control after undergoing a cell transformation.
Non-Small Cell Lung Cancer
- Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
html NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool Summary GBI Research, the leading business intelligence provider, has released its latest research, "NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool", which provides in-depth insights into the Non-Small Cell Lung Cancer
com/research/x7kq9k/randd_trends_non) has announced the addition of the "R&D Trends: Non-Small Cell Lung Cancer
- Mutation Analyses Continue Driving Treatment Choices" report to their offering.
com has added a new market research report: Non-Small Cell Lung Cancer
Global Clinical Trials Review, H1, 2014 http://www.
Four new chapters on the treatment of non-small cell lung cancer